O'SHAUGHNESSY ASSET MANAGEMENT, LLC

Position in EXEL — Exelixis, Inc.

CIK 1423442 Stamford, CT

Position in EXEL

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$5,569,952

-$52,034 QoQ

Shares Held

129,866

+1.2% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

O'SHAUGHNESSY ASSET MANAGEMENT, LLC holds $95,217,469 across 37 Biotechnology names. EXEL ranks #6 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	61,867	$27,626,090
2	REGN	Regeneron Pharmaceuticals, Inc.	13,256	$10,242,115
3	PBYI	Puma Biotechnology, Inc.	1,138,169	$7,272,899
4	JAZZ	Jazz Pharmaceuticals plc	34,435	$6,509,936
5	AUPH	Aurinia Pharmaceuticals Inc.	414,019	$6,135,761
6	EXEL	Exelixis, Inc. This page	129,866	$5,569,952
7	ARGX	Argenx SE	5,055	$3,691,413
8	RIGL	Rigel Pharmaceuticals Inc	125,662	$3,397,900

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,569,952	129,866	+1.2%	Shares	Sole	2026-05-13
2025-12-31	$5,621,986	128,268	-2.8%	Shares	Sole	2026-02-11
2025-09-30	$5,451,021	131,986	+16.5%	Shares	Sole	2025-11-13
2025-06-30	$4,992,324	113,256	+216.4%	Shares	Sole	2025-08-12
2025-03-31	$1,321,588	35,796	+269.8%	Shares	Sole	2025-05-13
2024-12-31	$322,310	9,679	+8.5%	Shares	Sole	2025-02-12
2024-09-30	$231,422	8,918	+6050.3%	Shares	Sole	2024-11-12
2021-09-30	$3,065	145	+49.5%	Shares	Sole	2021-11-10
2021-06-30	$1,767	97	-44.6%	Shares	Sole	2021-08-09
2021-03-31	$3,953	175	+52.2%	Shares	Sole	2021-05-14
2020-12-31	$2,308	115	-94.7%	Shares	Sole	2021-02-11
2020-09-30	$53,252	2,178	-11.4%	Shares	Sole	2020-11-12
2020-06-30	$58,352	2,458	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.